IGC Pharma (IGC) Interest Coverage Ratio (QoQ) (2010 - 2017)
IGC Pharma (IGC) Interest Coverage Ratio (QoQ) (2010 - 2017) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
IGC Pharma |
29.33 Mn |
29.07 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2017 |
-21.33% |
| Sep 30, 2017 |
27.59% |
| Jun 30, 2017 |
-5.33% |
| Mar 31, 2017 |
-1.63% |
| Dec 31, 2016 |
22.27% |
| Sep 30, 2016 |
-45.13% |
| Jun 30, 2016 |
-666.89% |
| Mar 31, 2016 |
86.94% |
| Dec 31, 2015 |
2.40% |
| Sep 30, 2015 |
-81.26% |
| Jun 30, 2015 |
-142.10% |
| Mar 31, 2015 |
222.53% |
| Dec 31, 2014 |
16.05% |
| Sep 30, 2014 |
48.96% |
| Jun 30, 2014 |
29.14% |
| Mar 31, 2014 |
-373.76% |
| Dec 31, 2013 |
10.92% |
| Sep 30, 2013 |
-170.36% |
| Jun 30, 2013 |
51.10% |
| Mar 31, 2013 |
-102.77% |
